Abstract: The invention provides an aqueous formulation comprising water and a protein, and methods of making the same. The aqueous formulation of the invention may be a high protein formulation and/or may have low levels of conductity resulting from the low levels of ionic excipients. Also included in the invention are formulations comprising water and proteins having low osmolality.

Abstract: The invention provides an aqueous formulation comprising water and a protein, and methods of making the same. The aqueous formulation of the invention may be a high protein formulation and/or may have low levels of conductity resulting from the low levels of ionic excipients. Also included in the invention are formulations comprising water and proteins having low osmolality.

Abstract: The invention provides an aqueous formulation comprising water and a protein, and methods of making the same. The aqueous formulation of the invention may be a high protein formulation and/or may have low levels of conductivity resulting from the low levels of ionic excipients. Also included in the invention are formulations comprising water and proteins having low osmolality.

Abstract: The invention provides an aqueous formulation comprising water and a protein, and methods of making the same. The aqueous formulation of the invention may be a high protein formulation and/or may have low levels of conductivity resulting from the low levels of ionic excipients. Also included in the invention are formulations comprising water and proteins having low osmolality.

Abstract: The invention provides an aqueous formulation comprising water and a protein, and methods of making the same. The aqueous formulation of the invention may be a high protein formulation and/or may have low levels of conductity resulting from the low levels of ionic excipients. Also included in the invention are formulations comprising water and proteins having low osmolality.

Abstract: The present disclosure provides stable, aqueous, buffered compositions comprising a high concentration of ABBV-8E12, such as a stable, aqueous buffered composition including ABBV-8E12 at a concentration of about 100 mg/ml, at least one buffer, an excipient, a surfactant, and optionally an antioxidant.

Abstract: The invention provides a stable formulation comprising an anti-EGFR antibody drug conjugate (ADC), including an anti-EGFR antibody, e.g., antibody 1, conjugated to an auristatin, e.g., MMAF, histidine, a sugar, and a surfactant.

Abstract: The invention provides an aqueous formulation comprising water and a protein, and methods of making the same. The aqueous formulation of the invention may be a high protein formulation and/or may have low levels of conductity resulting from the low levels of ionic excipients. Also included in the invention are formulations comprising water and proteins having low osmolality.

Abstract: A pipeline system in a linearly concentrating solar power station comprises at least one pipeline which is connected at one end to a converger and at a second end to a distributor. The converger and the distributor are arranged at a different geodetic height. When the converger lies on top pressurized gas can be fed into the converger and the distributor is connected to a drainage container. When the distributor lies on top pressurized gas can be fed into the distributor and the converger is connected to a drainage container. The drainage container is lower than the converter and the distributor.

Abstract: Method of maintaining or widening the long-term operating temperature range of a heat transfer medium and/or heat storage medium comprising a nitrate salt composition selected from the group consisting of alkali metal nitrate and alkaline earth metal nitrate and optionally alkali metal nitrite and alkaline earth metal nitrite, wherein the nitrate salt composition is brought into contact with an additive comprising the components nitric acid and/or nitrous acid and oxygen-comprising gas having an oxygen partial pressure which is equal to or greater than that in air and/or oxygen-generating compounds and optionally nitrogen oxides and/or compounds which generate further nitrogen oxide.

Abstract: The invention provides an aqueous formulation comprising water and a protein, and methods of making the same. The aqueous formulation of the invention may be a high protein formulation and/or may have low levels of conductivity resulting from the low levels of ionic excipients. Also included in the invention are formulations comprising water and proteins having low osmolality.

Abstract: The invention provides an aqueous formulation comprising water and a protein, and methods of making the same. The aqueous formulation of the invention may be a high protein formulation and/or may have low levels of conductivity resulting from the low levels of ionic excipients. Also included in the invention are formulations comprising water and proteins having low osmolality.

Abstract: The invention provides an aqueous formulation comprising water and a protein, and methods of making the same. The aqueous formulation of the invention may be a high protein formulation and/or may have low levels of conductity resulting from the low levels of ionic excipients. Also included in the invention are formulations comprising water and proteins having low osmolality.

Abstract: The invention provides an aqueous formulation comprising water and a protein, and methods of making the same. The aqueous formulation of the invention may be a high protein formulation and/or may have low levels of conductity resulting from the low levels of ionic excipients. Also included in the invention are formulations comprising water and proteins having low osmolality.

Abstract: The invention provides an aqueous formulation comprising water and a protein, and methods of making the same. The aqueous formulation of the invention may be a high protein formulation and/or may have low levels of conductity resulting from the low levels of ionic excipients. Also included in the invention are formulations comprising water and proteins having low osmolality.

Abstract: The invention provides a stable formulation comprising an anti-EGFR antibody drug conjugate (ADC), including an anti-EGFR antibody, e.g., antibody 1, conjugated to an auristatin, e.g., MMAF, histidine, a sugar, and a surfactant.

Abstract: Method of maintaining or widening the long-term operating temperature range of a heat transfer medium and/or heat storage medium comprising a nitrate salt composition selected from the group consisting of alkali metal nitrate and alkaline earth metal nitrate and optionally alkali metal nitrite and alkaline earth metal nitrite, wherein the nitrate salt composition is brought into contact with an additive comprising the components nitric acid and/or nitrous acid and oxygen-comprising gas having an oxygen partial pressure which is equal to or greater than that in air and/or oxygen-generating compounds and optionally nitrogen oxides and/or compounds which generate further nitrogen oxide.

Abstract: The invention relates to a pipeline system, comprising at least one pipeline loop (9) which is connected at one end to a converger (7) and at a second end to a distributor (5), wherein the converger (7) and the distributor (5) are arranged above one another, and when the converger (7) lies on top pressurized gas can be fed into the converger and the distributor (5) is connected to a drainage container (21), and when the distributor (5) lies on top pressurized gas can be fed into the distributor (5) and the converger (7) is connected to a drainage container (21), the drainage container (21) lying lower than the converger (7) and the distributor (5).

Abstract: Method of maintaining or widening the long-term operating temperature range of a heat transfer medium and/or heat storage medium comprising a nitrite salt composition comprising, as significant constituents, an alkali metal nitrate or an alkaline earth metal nitrate or a mixture of alkali metal nitrate and alkaline earth metal nitrate and in each case an alkali metal nitrite and/or alkaline earth metal nitrite, wherein all or part of the nitrite salt composition is brought into contact with an additive composed of nitrogen and/or noble gases, in each case with elemental oxygen, the latter in an amount in the range from 0 to 20% by volume based on the total amount of the additive in combination with nitrogen oxides and/or compounds which generate nitrogen oxide.

Abstract: Method of maintaining or widening the long-term operating temperature range of a heat transfer medium and/or heat storage medium comprising a nitrate salt composition selected from the group consisting of alkali metal nitrate and alkaline earth metal nitrate and optionally alkali metal nitrite and alkaline earth metal nitrite, wherein all or part of the nitrate salt composition is brought into contact with an additive composed of a combination of elemental oxygen and nitrogen oxides.